Skip to content

Apyx Medical Corporation APYX US — Non-Current Assets

Similar metrics at other companies

Donnelley Financial Solutions logo
DFINUS — Non-Current Assets
$134.6M-4.3%
Lightpath Technologies logo
LPTHUS — Non-Current Assets
$54.26M
NCS Multistage Holdings logo
NCSMUS — Non-Current Assets
$11.18M-12.1%
JAK
JAKKUS — Non-Current Assets
$40.54M-19.5%
Mesa Laboratories logo
MLABUS — Non-Current Assets
$29.89M+2.4%
PDF Solutions logo
PDFSUS — Non-Current Assets
$102.92M+53.9%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's us — non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's US — non-current assets?
Apyx Medical Corporation (APYX) reported US — non-current assets of $5.43M in Q1 2026.
How has Apyx Medical Corporation's US — non-current assets changed year-over-year?
Apyx Medical Corporation's US — non-current assets increased by 0.1% year-over-year, from $5.43M to $5.43M.
What does US — non-current assets mean?
This metric captures the total value of long-term assets held by the company within the United States segment that are not expected to be converted into cash within a single fiscal year. These assets typically include property, plant, equipment, and long-term investments essential for supporting domestic operations. Monitoring this balance provides insight into the company's capital intensity and the scale of infrastructure deployed to sustain its US-based business activities.